Aidapak Recalls Metoprolol Tablets Due to Potential Label Mixup
Aidapak Services is recalling Metoprolol Tartrate 25 mg tablets because they may be mislabeled as Ascorbic Acid or Amlodipine Besylate.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences. The hazard is a labeling error (mixup) rather than a contamination or structural defect, and no injuries are reported in the source text.
Plain-English summary
Aidapak Services, LLC is recalling Metoprolol Tartrate 25 mg tablets (NDC 57664050652) due to a labeling mixup. The FDA has identified that these prescription tablets may be potentially mislabeled as Ascorbic Acid 250 mg tablets or Amlodipine Besylate 5 mg tablets.
The affected Metoprolol Tartrate tablets were repacked and distributed in Arizona, California, Oregon, and Washington. The recall involves specific pedigree codes W003843 and W002841, with expiration dates of 6/27/2014 and 6/7/2014, respectively.
Consumers and healthcare providers should check their inventory for these specific NDC and pedigree codes. If the medication is found to be mislabeled, it should not be used. Patients should contact their healthcare provider for guidance on alternative treatments or to obtain the correct medication.
The recalled product
- Product
- METOPROLOL TARTRATE Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 57664050652
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 300
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- METOPROLOL TARTRATE
- Tablet
- 25 mg has the following codes Pedigree: W003843
- EXP: 6/27/2014
- Pedigree: W002841
- EXP: 6/7/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Metoprolol Tartrate Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateMetoprolol Tartrate Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Methocarbamol Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
- HighAidapak Recalls Acyclovir Capsules Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateDesloratadine Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29